Investigating the antibacterial effects and modes of action of two endophytic fungal extracts from Annona muricata seeds against resistant Staphylococcus aureus
Introduction and objective: Antimicrobial resistance in Staphylococcus aureus represents a major public health concern, highlighting the need for new antibacterial agents. Endophytic fungi associated with medicinal plants are promising sources of bioactive secondary metabolites for this purpose. This study therefore aimed to evaluate the antibacterial activity and investigate the modes of action of two ethyl acetate extracts of endophytic fungi isolated from Annona muricata seeds, against a resistant strain Staphylococcus aureus NR-46003. Methods: The broth microdilution method was used to determine the Minimum Inhibitory Concentrations (MICs) while the effects of the extracts on bacterial growth were assessed by growth kinetics. Additional assays examined cellular protein content, ethidium bromide accumulation, glucose-induced extracellular acidification and antibiofilm activity. Results: Both fungal extracts exhibited pronounced antibacterial potency, with MICs of 25 μg/mL and 12.5 μg/mL for P. citrinum AMs3 and Aspergillus sp. AMs9, respectively. Growth kinetics showed concentration-dependent inhibition, with complete suppression of visible growth at the MIC and higher concentrations over 24 h. Both extracts reduced cellular protein content, increased ethidium bromide retention, and attenuated glucose-induced extracellular acidification, findings consistent with effects on protein biosynthesis, efflux activity and proton transport. Moreover, both extracts demonstrated substantial antibiofilm activity, inhibiting biofilm formation by up to 73.63% and eradicating established biofilms by up to 64.71%. Conclusion: These findings provide compelling evidence supporting the pharmacological exploitation of P. citrinum AMs3 and Aspergillus sp. AMs9 as promising lead candidates for the development of innovative therapeutic interventions against resistant S. aureus infections. Keywords: Antimicrobial resistance, Penicillium citrinum AMs3, Aspergillus sp. AMs9.
Authors
- Fabrice Fekam Boyom (ORCID: https://orcid.org/0000-0002-3147-364X)
- Victorine Lorette Yimgang (ORCID: https://orcid.org/0000-0002-5849-9428)
- Pierre Michel Jazet Dongmo (ORCID: https://orcid.org/0000-0003-3576-8434)
- Ebenezer Tatiekam Foka (ORCID: https://orcid.org/0000-0002-0578-8429)
- Brice Rostan Pinlap (ORCID: https://orcid.org/0009-0002-7615-6565)
- Emmanuel Souana
Publication Details
- Journal
- Journal of Drug Delivery and Therapeutics
- Published
- 2026-11-15
- DOI
- https://doi.org/10.22270/jddt.v16i11.8088
- Primary Topic
- Microbial Natural Products and Biosynthesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00